↓ Skip to main content

TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy

Overview of attention for article published in Clinical Cancer Research, October 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
wikipedia
2 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy
Published in
Clinical Cancer Research, October 2011
DOI 10.1158/1078-0432.ccr-11-1142
Pubmed ID
Authors

Hailing Lu, Yi Yang, Ekram Gad, Carol Inatsuka, Cynthia A. Wenner, Mary L. Disis, Leanna J. Standish

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
United States 1 1%
Cyprus 1 1%
Austria 1 1%
Unknown 86 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 22%
Student > Master 13 14%
Other 9 10%
Student > Bachelor 7 8%
Student > Ph. D. Student 7 8%
Other 14 16%
Unknown 20 22%
Readers by discipline Count As %
Medicine and Dentistry 24 27%
Agricultural and Biological Sciences 18 20%
Biochemistry, Genetics and Molecular Biology 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Immunology and Microbiology 3 3%
Other 9 10%
Unknown 24 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2023.
All research outputs
#3,198,724
of 24,590,593 outputs
Outputs from Clinical Cancer Research
#2,818
of 13,056 outputs
Outputs of similar age
#17,006
of 145,441 outputs
Outputs of similar age from Clinical Cancer Research
#16
of 109 outputs
Altmetric has tracked 24,590,593 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,056 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 145,441 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.